DuPont sees earning slide in TiO2, fluorochemicals, arm – but outlook good
Published: Tuesday, 22 April 2014
While the slide in earnings in the segment which encompasses the titanium dioxide (TiO2) business is not exactly positive, an increase in volume and positive remarks from the both the CFO and CEO of DuPont mark a change as we go into Q2.
DuPont said in its Q1 results that its operating earnings
fell in its performance chemical arm, which encompasses its
fluorochemicals and titanium dioxide (TiO2) business, due
to lower selling prices.
"Operating earnings of $200m were down (...) 20% due...